Prediction of an HLA-DR-binding peptide derived from Wilms’ tumour 1 protein and demonstration of in vitro immunogenicity of WT1(124–138)-pulsed dendritic cells generated according to an optimised protocol
Ashley Knights(University of Tübingen), Ludmila Müller(Max Planck Institute for Human Development), Angeliki Zaniou(Nottingham Trent University), Graham Pawelec(Health Sciences North), Robert C. Rees(Avillion (United Kingdom))
Cited by 37
Related Papers
Cancer classification using the Immunoscore: a worldwide task force
|Journal of Translational Medicine|2012|803
Relationships Between Immune Landscapes, Genetic Subtypes and Responses to Immunotherapy in Colorectal Cancer
|Frontiers in Immunology|2020|560
The Immune System and Its Dysregulation with Aging
|Sub-cellular biochemistry/Subcellular biochemistry|2019|308
Contribution of neuroinflammation and immunity to brain aging and the mitigating effects of physical and cognitive interventions
|Neuroscience & Biobehavioral Reviews|2017|288
CMV and Immunosenescence: from basics to clinics
|Immunity & Ageing|2012|182